ETHEX Recall

Nationwide ETHEX Recall Lawsuits

Update: 1/28/2009 - The U.S Food & Drug Administration in association with ETHEX Corporation has issued another nationwide recall of many products.  You can view the full recall list by clicking here, or by scrolling down on this page to the section titled, “Which ETHEX drugs are subject to recall?”

November 7, 2008 the U.S. Food & Drug Administration in association with ETHEX Corporation announced an urgent nationwide recall of five generic /non-branded pharmaceutical products.  The recalled lots have been pulled from market as a precaution, due to the possibility that they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in patients receiving as much as about twice the expected dosage of these drugs.

Which ETHEX drugs are subject to recall?

Products Recalled to WHOLESALE Level:

Amlodipine Besylate Tablets, 10mg (58177-538-26 & 538-11)
Amlodipine Besylate Tablets, 2.5mg (58177-536-26)
Amlodipine Besylate Tablets, 5mg (58177-537-26, 537-07 & 537-11)
Benazepril HCl Tablets, 10mg (58177-342-04 & 342-08)
Benazepril HCl Tablets, 20mg (58177-343-04 & 343-08)
Benazepril HCl Tablets, 40mg, (58177-344-04 & 344-08)
Benazepril HCl Tablets, 5mg (58177-341-04)
Benzonatate Capsules, 100mg (58177-091-04 & 091-08) 
Benzonatate Capsules, 200mg (58177-092-04 & 092-08)
Bromfenex ER Capsules (58177-019-04)
Bromfenex PD ER Capsules (58177-020-04)
Buspirone HCl Tablets, 10mg (58177-265-04 & 265-08)
Buspirone HCl Tablets, 15mg (58177-309-04 & 309-08)
Buspirone HCl Tablets, 5mg (58177-264-04 & 264-08)

Codeine Phosphate/Guaifenesin Tablets, 10mg (58177-223-04) 
Dextroamphetamine Sulfate Tablets, 10mg (58177-312-04)
Dextroamphetamine Sulfate Tablets, 5mg (58177-311-04)
Dextroamphetamine Tablets, 10mg (58177-312-04)
Diltiazem HC1 Capsules, 120mg (58177-061-11) 
Diltiazem HC1 Capsules, 120mg (58177-061-19 & 061-26)
Diltiazem HC1 Capsules, 180mg (58177-062-09 & 062-11)
Diltiazem HC1 Capsules, 180mg (58177-062-19 & 062-26)
Diltiazem HC1 Capsules, 240mg (58177-063-09 & 063-11)
Diltiazem HC1 Capsules, 240mg (58177-063-19 & 063-26)
Diltiazem HC1 Capsules, 300mg (58177-064-19 & 064-26)
Diltiazem HC1 Capsules, 360mg (58177-065-09 & 065-11)
Diltiazem HC1 Capsules, 360mg (58177-065-19 & 065-26)
Diltiazem HC1 Capsules, 420mg (58177-066-09 & 066-11)
Diltiazem HC1 Capsules, 420mg (58177-066-19 & 066-26)
Disopyramide Phosphate ER Capsules, 150mg (58177-002-04)
Doxazosin Mesylate Tablets, 1mg (58177-266-04 & 266-08)
Doxazosin Mesylate Tablets, 2mg (58177-267-04 & 267-08)
Doxazosin Mesylate Tablets, 4mg (58177-268-04 & 268-08)
Doxazosin Mesylate Tablets, 8mg (58177-269-04 & 269-08)
Ethedent Chewable Tablets, .25mg (58177-432-40)
Ethedent Chewable Tablets, .5mg (58177-433-40 & 433-09)
Ethedent Chewable Tablets, 1mg (58177-434-40 & 434-09)
EthexDerm BPW-10, 10% (58177-929-65)
EthexDerm BPW-5, 5%    (58177-928-65)
Ethezyme 650 (58177-868-02)
Ethezyme 830 Papain-Urea (58177-816-02)
Ethezyme Papain-Urea (58177-804-02)
ETH-Oxydose Concentrated Solution (58177-914-04 & 914-56)
Guaifenex DM ER Tablets (58177-213-04) 
Guaifenex GP ER Tablets (58177-373-04) 
Guaifenex PSE 120 ER Tablets (58177-208-04) 
Guaifenex PSE 60 ER Tablets (58177-214-04) 
Guaifenex PSE 80 Tablets (58177-413-04) 
Guaifenex PSE 85 Tablets (58177-478-04)
Hista-Vent DA Tablets (58177-227-04)
Hista-Vent PSE tablets (58177-426-04)
Histinex HC Liquid (58177-877-07 & 877-12)
Histinex PV Liquid (58177-883-07)
Hydrocodone Bitartrate & Acetaminophen Liquid     (58177-909-07)
Hydrocodone Bitartrate/Guaifenesin Liquid (58177-881-07)
Hydrocortisone and Iodoquinol Cream, 1%   (58177-803-02)
Hydroquinone 4% Cream w/SS, 1oz. (58177-802-02)
Hydroquinone 4% Cream, 1oz. (58177-801-02)
Hydro-Tussin CBX Liquid (58177-924-07)
Hydro-Tussin DHC Syrup (58177-926-07)
Hydro-Tussin DM Liquid (58177-906-07)
Hydro-Tussin EXP Liquid (58177-927-07)
HydroTussin HC Syrup (58177-915-07)
Hydro-Tussin Liquid (58177-890-07)
Hydro-Tussin XP Liquid (58177-916-07)
Hyoscyamine Orally Disintegrating Tablets, .125mg (58177-423-04)
Hyoscyamine Sublingual Tablets, .125mg (58177-255-04)
Hyoscyamine Sulfate ER   Tablets, .375mg (58177-237-04)
Hyoscyamine Sulfate ER Capsules, .375mg (58177-017-04)
Hyoscyamine Sulfate Oral Tablets, .125mg (58177-274-04)
Isosorbide Mononitrate ER Tablets, 120mg (58177-201-04)

Isosorbide Mononitrate ER Tablets, 30mg (58177-222-04, 222-08 & 222-11)
Isosorbide Mononitrate ER Tablets, 60mg (58177-238-04, 238-08 & 238-11)
Meperidine/Promethazidne Capsules (58177-027-04) 
Morphine InveAmp, 20mg x 1mL (58177-886-56)
Morphine InveAmp, 5mg/.25mL (58177-888-80) 
Morphine Sulfate Concentrated Oral Solution 20mg/1ml   (58177-886-01, 886-03 &886-05)
Morphine Sulfate Concentrated Oral Solution, 20mg/1ml   (58177-886-57)
Morphine Sulfate ER Tablets, 100mg (58177-340-04)
Morphine Sulfate ER Tablets, 15mg (58177-310-04)
Morphine Sulfate ER Tablets, 200mg (58177-380-04)
Morphine Sulfate ER Tablets, 30mg (58177-320-04)
Morphine Sulfate ER Tablets, 60mg (58177-330-04)
Morphine Sulfate IR Tablets, 15mg (58177-313-04)
Morphine Sulfate IR Tablets, 30mg (58177-314-04)
NitroQuick Sublingual Tablets, .3mg (58177-323-04)
NitroQuick Sublingual Tablets, .4mg (58177-324-18 & 324-04)
NitroQuick Sublingual Tablets, .6mg (58177-325-04)
Nystatin Topical Powder,  USP 15 grams (58177-839-45)
Nystatin Topical Powder, USP 30 grams (58177-839-46)
Nystatin Topical Powder, USP 60 grams (58177-839-61)
Ondansetron Orally Disintegrating Tablets, 4mg (58177-363-22)
Ondansetron Orally Disintegrating Tablets, 8mg (58177-364-22 & 364-56)
Oxycodone HCl Capsules, 5mg   (58177-041-04 & 041-11)
Oxycodone HCl IR Tablets,  10mg (58177-461-04)
Oxycodone HCl IR Tablets,  15mg, (58177-445-04)
Oxycodone HCl IR Tablets,  20mg (58177-462-04)
Oxycodone HCl IR Tablets, 30mg (58177-446-04)
Oxycodone HCl IR Tablets, 5mg (58177-625-04 & 625-11)
Pangestyme CN 20 (58177-030-04)
Pangestyme CN10   (58177-029-04)
Pangestyme EC 100 (58177-031-04)
Pangestyme EC 250   (58177-031-06)
Pangestyme MT16  (58177-028-04)
Pangestyme UL12  (58177-048-04)
Pangestyme UL18  (58177-049-04)
Pangestyme UL20   (58177-050-04) 
PhenaVent Capsules (58177-078-19)
PhenaVent D Tablets (58177-444-04)
PhenaVent LA Capsules (58177-095-19)
PhenaVent PED Capsules (58177-079-04)
Plaretase 800  (58177-416-04 & 416-08)
Potassium Chloride ER Capsules, 10mEq (58177-001-04, 001-08, 001-09, & 001-11)
Potassium Chloride ER Capsules, 8mEq (58177-677-04 & 677-08)
Potassium Chloride ER Tablets, 20mEq (58177-202-04, 202-08, 202-09 & 202-11)
Prednisolone Sodium Oral Solution (58177-932-05)
Prednisolone Syrup 15mg/5mL  (58177-910-05 & 910-07)
Prednisolone Syrup 5mg/5mL (58177-912-03)
Propafenone HCl Tablets, 150mg (58177-331-04 & 331-11)
Propafenone HCl Tablets, 225mg (58177-332-04)
Propafenone HCl Tablets, 300mg (58177-333-04)
Pseudovent 400 Capsules (58177-096-04)
Pseudovent Capsules (58177-045-04)
Pseudovent PED Capsules (58177-046-04)
Tri-Vent DM Syrup (58177-925-07)
Tri-Vent DPC Liquid (58177-923-07)
Tri-Vent HC Liquid (58177-920-07)

Products Recalled to RETAIL PHARMACY Level:

Hydromorphone HCl Tablets, 2mg (58177-620-04 & 620-11) 
Hydromorphone HCl Tablets, 4mg (58177-621-04 & 621-11)
Hydromorphone HCl Tablets, 8mg (58177-449-04)
Metoprolol Succinate ER Tablets, 50mg (58177-369-04, 369-09 & 369-11)
Metoprolol Succinate ER Tablets, 100mg (58177-368-04, 368-09 & 368-11)
Metoprolol Succinate ER Tablets, 25mg (58177-293-04, 293-09 & 293-11)
Metoprolol Succinate ER Tablets, 200mg (58177-358-04, 358-09 & 358-11)

What are the potential side effects?

The most dangerous side effect would be that a patient could overdose on an aformentioned medication and die as a result.  The other side effects associated with this recall are specific to the drug the patient is taking …

Overdoses of Propafenone HCl, Isosorbide Mononitrate, Morphine sulfate and Dextroamphetamine Sulfate can have serious or life-threatening consequences. In the case of Propafenone HCl, these consequences can include arrhythmias (irregular heartbeat) and low blood pressure. In the case of Isosorbide Mononitrate, these consequences can include fainting and low blood pressure. In the case of Morphine Sulfate, these consequences can include respiratory depression (difficulty or lack of breathing) and low blood pressure. In the case of Dextroamphetamine Sulfate, these consequences can include rapid heart rate and high blood pressure.

Do I Have a Lawsuit?

If you or somebody you know has been injured or died as a result of the negligent manufacturing practices of ETHEX Corporation, you should contact us immediately.  You may be entitled to compensation for your injuries or loved ones loss and we can help.  Please use the form below to contact and experienced drug recall trial attorney / trial lawyer.

Dextroamphetamine Sulfate Tablet Recall Lawsuit

Update: 1/28/2009 - The U.S Food & Drug Administration in association with ETHEX Corporation has issued another nationwide recall of many products.  You can view the full recall list by clicking here.

On November 7, 2008 the U.S. Food & Drug Administration (FDA) in association with ETHEX Corporation issued an urgent nationwide recall of Dextroamphetamine Sulfate Tablets. The Dextroamphetamine Sulfate Tablets been recalled as a precaution, due to the possibility that they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in patients receiving as much as about twice the expected dosage of these drugs.

Dextroamphetamine Sulfate Tablet Recall List

Dextroamphetamine Sulfate Tablets, 10 mg: Lots: 73934, 75892, 77945, 81137, 86320 with expiration dates ranging from 6/2009 to 5/2011

Overdoses of Dextroamphetamine Sulfate Tablets can have serious, life-threatening consequences. In the case of Dextroamphetamine Sulfate, these consequences can include rapid heart rate and high blood pressure.

Do I Have a Dextroamphetamine Sulfate Tablet Recall Lawsuit?

If you or a loved one have experienced a serious side effect related to the recall of Dextroamphetamine Sulfate Tablets, you should contact us immediately. You may be entitled to compensation for your injuries and we can help. Please use the form below for a free case evaluation.

Morphine Sulfate Extended Release Tablet Recall Lawsuit

Update: 1/28/2009 - The U.S Food & Drug Administration in association with ETHEX Corporation has issued another nationwide recall of many products.  You can view the full recall list by clicking here.

On November 7, 2008 the U.S. Food & Drug Administration (FDA) in association with ETHEX Corporation issued an urgent nationwide recall of Morphine Sulfate Extended Release Tablets. The Morphine Sulfate Extended Release Tablets been recalled as a precaution, due to the possibility that they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in patients receiving as much as about twice the expected dosage of these drugs.

Morphine Sulfate Extended Release Tablet Recall List

Morphine Sulfate Extended Release Tablets, 15 mg: Lots: 81175, 82514-16, 89660, 89664, 89667, 90249-51, and 91687 with expiration dates ranging from 12/2008 to 2/2010

Morphine Sulfate Immediate Release Tablets, 15 mg: Lots: 77852-54, 81746, 82519-20, 84113, and 90276-78 with expiration dates ranging from 9/2009 to 1/2011

Morphine Sulfate Immediate Release Tablets, 30 mg: Lots: 75093, 77855-57, 82297, 82521-22, 87239, 88925, and 90288-98 with expiration dates ranging from 8/2009 to 3/2011

Overdoses of Morphine Sulfate Extended Release Tablets can have serious, life-threatening consequences. In the case of Morphine Sulfate, these consequences can include respiratory depression (difficulty or lack of breathing) and low blood pressure.

Do I Have a Morphine Sulfate Extended Release Tablet Recall Lawsuit?

If you or a loved one have experienced a serious side effect related to the recall of Morphine Sulfate Extended Release Tablets, you should contact us immediately. You may be entitled to compensation for your injuries and we can help. Please use the form below for a free case evaluation.

Isosorbide Mononitrate Extended Release Tablet Recall Lawsuit

Update: 1/28/2009 - The U.S Food & Drug Administration in association with ETHEX Corporation has issued another nationwide recall of many products.  You can view the full recall list by clicking here.

On November 7, 2008 the U.S. Food & Drug Administration (FDA) in association with ETHEX Corporation issued an urgent nationwide recall of Isosorbide Mononitrate Extended Release Tablets. The Isosorbide Mononitrate Extended Release Tablets been recalled as a precaution, due to the possibility that they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in patients receiving as much as about twice the expected dosage of these drugs.

Isosorbide Mononitrate Extended Release Tablet Recall List

Isosorbide Mononitrate Extended Release Tablets, 30 mg: Lots: 62355, 66423, and 68102 with expiration dates ranging from 11/2008 to 8/2009

Isosorbide Mononitrate Extended Release Tablets, 60 mg: Lots: 63466, 66034, 67351, and 67354 with expiration dates ranging from 12/2008 to 11/2009

Overdoses of Isosorbide Mononitrate Extended Release Tablets can have serious, life-threatening consequences. In the case of Isosorbide Mononitrate, these consequences can include fainting and low blood pressure.

Do I Have an Isosorbide Mononitrate Extended Release Tablet Recall Lawsuit?

If you or a loved one have experienced a serious side effect related to the recall of Isosorbide Mononitrate Extended Release Tablets, you should contact us immediately. You may be entitled to compensation for your injuries and we can help. Please use the form below for a free case evaluation.

Propafenone HCl Tablet Recall Lawsuit

Update: 1/28/2009 - The U.S Food & Drug Administration in association with ETHEX Corporation has issued another nationwide recall of many products.  You can view the full recall list by clicking here.

On November 7, 2008 the U.S. Food & Drug Administration (FDA) in association with ETHEX Corporation issued an urgent nationwide recall of Propafenone HCl Tablets. The Propafenone HCl Tablets been recalled as a precaution, due to the possibility that they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in patients receiving as much as about twice the expected dosage of these drugs.

Propafenone HCl Tablet Recall List

Propafenone HCl Tablets, 150 mg: Lots: 73761, 78184, 79373, 81240, 81241, 81242, 83470, 84357, 90525, and 90526 with expiration dates ranging from 3/2009 to 3/2011

Propafenone HCl Tablets, 225 mg: Lots: 71720, 74831, 76014-15, 81243-45, 89731, 90527-29, and 90657 with expiration dates ranging from 3/2009 to 2/2011

Propafenone HCl Tablets, 300 mg: Lots: 72834, 76016-18, 81246, 89092, 89732, 90530, 90532, and 91641-42 with expiration dates ranging from 6/2009 to 3/2011

Overdoses of Propafenone HCl can have serious, life-threatening consequences. In the case of Propafenone HCl, these consequences can include arrhythmias (irregular heartbeat) and low blood pressure.

Do I Have a Propafenone HCl Tablet Recall Lawsuit?

If you or a loved one have experienced a serious side effect related to the recall of Propafenone HCl Tablets, you should contact us immediately. You may be entitled to compensation for your injuries and we can help. Please use the form below for a free case evaluation.